Skip to content
Search

Latest Stories

India's Reliance Industries explores bid for Walgreens' Boots business: Bloomberg News

Indian billionaire Mukesh Ambani's Reliance Industries is exploring a bid for Boots UK, Bloomberg News reported last week, citing people familiar with the matter.

Walgreens Boots Alliance is selling its UK-based Boots business as part of an auction process led by Goldman Sachs and can be valued at up to £8 billion, Reuters reported in February, citing sources.


The Boots business spans across 2,200 stores in the UK, including pharmacies, health and beauty stores, according to the chain's website.

Deliberations were ongoing and there was no certainty Reliance, one of the world’s largest multinational conglomerates and India's largest private sector company, would actually bid for Boots, the Bloomberg report quoted people who asked not to be identified as the information was confidential.

While a spokesperson for Boots declined to comment on the news, Reliance was not available for response either.

The Mumbai-headquartered Reliance Industries -- which has already acquired NetMeds, an online medicine seller -- has grown on the back of its oil and petrochemicals business. In recent years it has expanded into other sectors including retail, entertainment and telecoms.

Boots UK will be a major global investment attempt by Reliance after its unsuccessful foray into the US shale gas market.

Meanwhile, US-based Walgreens said in January it was conducting a strategic review of the Boots business as the second largest US pharmacy chain renews its focus on domestic healthcare.

A news report earlier in the month indicated that WBA could risk losing billions after a private equity firm interested in buying Boots UK valued the retailer at a steep discount.

In addition to a consortium of CVC Capital Partners and Bain Capital, other suitors for Boots include TDR Capital, which owns supermarket chain Asda, US investment firm Apollo Global Management and Sycamore Capital.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less